Vigilant vector: Heart-specific promoter in an adeno-associated virus vector for cardioprotection

Hypertension

Volumn 39, Issue 2 II, 2002, Pages 651-655

  Phillips, M Ian ^a   Tang, Yi ^a   Schmidt Ott, Kai ^a   Qian, Keping ^a   Kagiyama, Shuntaro ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Cardiac function; Gene therapy; Hypoxia; Ischemia; Myosin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; BETA 1 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; GREEN FLUORESCENT PROTEIN; HEME OXYGENASE; MESSENGER RNA; SUPEROXIDE DISMUTASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENE THERAPY; HEART; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; KIDNEY; LUNG; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SPLEEN; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TREATMENT INDICATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE THERAPY; GENETIC VECTORS; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL ISCHEMIA; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN;

EID: 0036178177     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy0202.103472     Document Type: Conference Paper

References (25)

1. Current concepts of silent myocardial ischmiea
2. Stable therapeutic serum levels of human alpha-1 antitrypsin (hAAT) after protein vein injection of recombinant adeno-associated viral (rAAV) vectors
3. 1-R mRNA antisense
4. Increase in angiotensin II type I receptor expression immediately after ischemia-reperfusion in isolated rat hearts
5. Cardiac-specific expression of heme oxygenase-2 protects against ischemia and reperfusion injury in transgenic mice
6. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits
7. Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory program for cardiac and skeletal muscle-specific expression of a single contractile protein gene
8. Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-based pair fragment which confers cardiac-specific expression
9. Molecular basis for familial hypertrophic cardiomyopathy: A cardiac myosin heavy chain gene missense mutation
10. A conversed 28-base-pair element (HF-1) in the rat cardiac myosin light-chain-2 gene confers cardiac-specific and alpha-adrenergic-inducible expression in cultured neonatal rat myocardial cells
11. Positive regulatory elements (HF-1a) and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light chain 2-luciferase fusion genes in transgene mice
12. Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors
13. Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac- specific promoters
14. Hypoxia response elements in the aldolase A. enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
15. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia
16. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
17. Regulation of hypoxia-inducbile factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway
18. 2 tension
19. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension
20. Properties of a clonal muscle cell line from rat heart
21. Hypoxia inducible double plasmid system for myocardial ischemia gene therapy
22. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization
23. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation
24. A regulatory system for use in gene transfer
25. Binary system for regulating transgene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements